Ferdinand Luger

Linz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial.

External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial.

Journal: The Journal of urology

Published: April 28, 2026

Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer.

Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer.

Journal: BJU international

Published: February 16, 2026

Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis.

Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis.

Journal: International journal of cancer

Published: May 05, 2025

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.

Journal: JAMA

Published: March 23, 2025

Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.

Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.

Journal: Clinical genitourinary cancer

Published: October 08, 2024

Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.

Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.

Journal: Clinical genitourinary cancer

Published: October 12, 2023

Importance of genetic testing in prostate cancer

Importance of genetic testing in prostate cancer

Journal: Urologie (Heidelberg, Germany)

Published: October 25, 2022

A non-inferiority comparative analysis of micro-ultrasonography and MRI-targeted biopsy in men at risk of prostate cancer.

A non-inferiority comparative analysis of micro-ultrasonography and MRI-targeted biopsy in men at risk of prostate cancer.

Journal: BJU international

Published: January 28, 2021

Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis.

Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: July 24, 2020

Immunotherapy for locally advanced and metastasized bladder cancer

Immunotherapy for locally advanced and metastasized bladder cancer

Journal: Der Urologe. Ausg. A

Published: October 11, 2018

Castration-resistant prostate cancer (CRPC)

Castration-resistant prostate cancer (CRPC)

Journal: Der Urologe. Ausg. A

Published: March 12, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026